Market closedNon-fractional

Biodesix/BDSX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Biodesix

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Ticker

BDSX

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Providers and Services

Headquarters

Louisville, United States

Employees

217

Biodesix Metrics

BasicAdvanced
$228M
Market cap
-
P/E ratio
-$0.54
EPS
1.14
Beta
-
Dividend rate
$228M
1.14
0.912
0.685
-1,112.141
-1,124.228
-3.71%
-26.71%
9,886.13%
2.489
-27.75
-5.47
-2.96
34.70%
-57.53%
-7.51%
-39.98%

What the Analysts think about Biodesix

Analyst Ratings

Majority rating from 4 analysts.
Buy

Biodesix Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-91.89% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$15M
1.37%
Net income
-$14M
49.45%
Profit margin
-91.89%
47.45%

Biodesix Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 2.33%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.17
-$0.14
-$0.10
-$0.14
-
Expected
-$0.21
-$0.15
-$0.11
-$0.14
-$0.09
Surprise
-17.74%
-6.67%
-9.09%
-2.33%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Biodesix stock?

Biodesix (BDSX) has a market cap of $228M as of July 06, 2024.

What is the P/E ratio for Biodesix stock?

The price to earnings (P/E) ratio for Biodesix (BDSX) stock is 0 as of July 06, 2024.

Does Biodesix stock pay dividends?

No, Biodesix (BDSX) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Biodesix dividend payment date?

Biodesix (BDSX) stock does not pay dividends to its shareholders.

What is the beta indicator for Biodesix?

Biodesix (BDSX) has a beta rating of 1.14. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Biodesix stock

Buy or sell Biodesix stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing